The fibrinolytic system and thrombotic tendency

Area of Science:

• Biochemistry
• Molecular Biology
• Physiology

Background:

• Fibrin deposition forms a temporary protein matrix crucial for hemostasis.
• Proteolytic removal of fibrin is primarily mediated by plasmin, generated from plasminogen.
• Plasminogen deficiency can occur without significant fibrin deposition or thrombosis, suggesting alternative degradation routes.

Purpose of the Study:

• To investigate alternative fibrin degradation pathways beyond the classical plasminogen-plasmin system.
• To explore the roles of other enzymes, such as leucocytal elastase, cathepsin G, and matrix metalloproteinases (MMPs), in fibrinolysis.
• To understand the relative importance and interplay of these diverse fibrinolytic mechanisms in various physiological and pathological contexts.

Main Methods:

• Literature review of reported direct fibrinolytic activities of various enzymes.
• Conceptual proposal for creating multiple combined knock-out models to evaluate distinct fibrinolytic pathways.
• Phenotypic analysis of these models to assess fibrin accumulation and thrombotic events.

Main Results:

• Several enzymes, including leucocytal elastase, cathepsin G, MMP-3, MMP-7, and MT1-MMP, exhibit direct fibrinolytic activity.
• The precise contribution and significance of each alternative pathway in different disease states, acute conditions, and anatomical locations remain largely unknown.
• The study suggests that multiple, combined deficiencies in fibrinolytic mechanisms are likely required to cause pathological fibrin accumulation.

Conclusions:

• Fibrin removal is a complex biological process with multiple redundant or buffering mechanisms.
• Disruptions in a single fibrinolytic pathway may not be sufficient to cause thrombotic events.
• Pathological fibrin accumulation and thrombosis likely result from combined abnormalities in various fibrin removal mechanisms under specific physiological or pathological conditions.